Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction

Completed

Conditions studied: Acute Coronary Syndromes

In brief

While troponin is not detectable until several hours after an Acute Myocardial Infarction (AMI), copeptin is expected to be elevated very early after an AMI. A combination of both markers for the diagnosis of AMI early after the event is therefore expected to be advantageous.

Key facts

Study ID
NCT00952744
Run by
Brahms AG
People needed
2071
Starts
2009-08-01
Expected to finish
2011-10-01
Last updated by the study team
2012-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.